testing for amphetamine-type stimulant (ats) use to ascertain validity of self-reported ats use among young female sex workers in cambodia测试非兴奋剂(ats)用来确定自我报告的有效性at柬埔寨在年轻女性性工作者使用.pdfVIP

下载本文档

1
0
约5.81万字
约 7页
2017-09-12 发布于上海
举报
版权申诉

testing for amphetamine-type stimulant (ats) use to ascertain validity of self-reported ats use among young female sex workers in cambodia测试非兴奋剂(ats)用来确定自我报告的有效性at柬埔寨在年轻女性性工作者使用.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

testing for amphetamine-type stimulant (ats) use to ascertain validity of self-reported ats use among young female sex workers in cambodia测试非兴奋剂(ats)用来确定自我报告的有效性at柬埔寨在年轻女性性工作者使用

Kab et al. Addiction Science Clinical Practice 2012, 7:11 /content/7/1/11 RESEARCH Open Access Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia 1 2 3 2 2 4 Vannda Kab , Jennifer Evans , Neth Sansothy , Ellen Stein , Marie Claude-Couture , Lisa Maher and Kimberly Page2* on behalf of the Young Women’s Study Collaborative Abstract Objective: To assess concordance between self-reported amphetamine-type stimulant (ATS) use and toxicology results among young female sex workers (FSW) in Phnom Penh, Cambodia. Methods: Cross-sectional data from the Young Women’s Health Study-2 (YWHS-2), a prospective study of HIV and ATS use among young (15 to 29 years) FSW in Phnom Penh, Cambodia, was analyzed. The YWHS-2 assessed sociodemographic characteristics, HIV serology, HIV risk, and ATS use by self-report and urine toxicology testing at each quarterly visit, the second of which provided data for this assessment. Outcomes include sensitivity, specificity, positive- and negative predictive values (overall and stratified by age), sex-work setting, and HIV status. Results: Among 200 women, prevalence of positive toxicology screening for ATS use was 14% (95% confidence interval [CI], 9.2, 18.9%) and concurrent prevalence of self-reported ATS was 15.5% (95% CI, 10.4, 20.6%). The sensitivity and specificity of self-reported ATS use compared to positive toxicology test results was 89.3% (25/28), and 96.5% (166/172), respectively. The positive predictive value of self-reported ATS use was 80.6% (25/31); the negative predictive value was 98.2% (166/169). Some differences in concordance between self-report and urine to